<DOC>
	<DOC>NCT01571518</DOC>
	<brief_summary>After resection of lymph node positive breast cancer, the injection duration and timing of Granulocyte-colony stimulating factor (G-CSF) could affect the neutropenia with TAC (Taxotere, Adriamycin, cyclophosphamide) chemotherapy.</brief_summary>
	<brief_title>Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy</brief_title>
	<detailed_description>The duration and the injection timing of G-CSF are effective in the prevention of neutropenia, incidence of infection and non hematologic toxicity. With the TAC chemotherapy after resection of breast cancer, the G-CSF early injection versus late injection could change the frequency of neutropenia.</detailed_description>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>primary invasive breast carcinoma with lymph node positive with curative surgery with TAC chemotherapy pregnancy, cardiovascualr disease, abnormal renal function, hematologic disorder</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>G-CSF</keyword>
	<keyword>neutropenia</keyword>
	<keyword>TAC</keyword>
</DOC>